問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberALXN2220-ATTRCM-301
NCT Number(ClinicalTrials.gov Identfier)-
Active

2023-12-15 - 2028-06-30

Phase III

Recruiting6

ICD-10E85.0

Non-neuropathic heredofamilial amyloidosis

ICD-10E85.1

Neuropathic heredofamilial amyloidosis

ICD-10E85.2

Heredofamilial amyloidosis, unspecified

ICD-10E85.3

Secondary systemic amyloidosis

ICD-10E85.4

Organ-limited amyloidosis

ICD-10E85.8

Other amyloidosis

ICD-10E85.9

Amyloidosis, unspecified

ICD-9277.3

Amyloidosis

-

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/13

Investigators and Locations

Principal Investigator Wen-Chung Yu Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator CHIH-HUNG LAI Division of Cardiovascular Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yen-Wen Wu

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Kuan-Cheng Chang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    40 participants

  • Global

    1000 participants